Q/C TECHNOLOGIES, INC. — Director's Dealing 2015

Jan 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Akers Biosciences Inc (AKER)
CIK: 0001321834
Period of Report: 2015-01-09

Reporting Person: AKERS RAYMOND FRANCIS JR (Director, Executive Chairman, Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-09	Common Stock	A	70000	—	Acquired	70000	Direct
2015-01-09	Common Stock	G	70000	—	Disposed	70000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-12	Options to purchase common stock	$5.50	G	40000	Disposed	2019-06-10	Common Stock (40000)	Indirect

Footnotes

F1: On January 9, 2015, pursuant to the Company's Amended and Restated 2013 Incentive Stock and Award Plan, Dr. Raymond F. Akers, Jr. was granted 70,000 shares of the Company's restricted common stock (the "Shares"). Upon receipt, Dr. Akers gifted the Shares to the Akers Family Trust, a trust to which he is not a named beneficiary.

F2: On January 12, 2015 Dr. Akers also gifted 40,000 optons to purchase common stock, originally granted on June 10, 2014, to the Akers Family Trust.